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Background: Bluetongue is a vector-bornedisease of ruminants
caused by bluetongue virus (BTV) belonging to Reoviridae. So far, 28
serotypes of BTV have been reported, and distribution of various
serotypes is not uniform among different geographical areas. The
virus is endemic in tropical areas where vector population is abun-
dant and these areas act as source population for virus spread to the
neighbouring temperate sink areas. Australasia is one of the sta-
ble source-sink episystems with circulation of different serotypes.
During this study, genetic relations of the serotypes circulating in
the Australasian region were analysed and the serotypes that are
unique to this episystem and those which entered this episystem
during recent past were identiﬁed.
Methods&Materials: Data about BTV serotypes circulating and
genome sequence were collected from public databases. Phyloge-
netic analysis was done using MEGA and BEAST.
Results: Majority of the BTV serotypes circulating in Australa-
sia are either unique (BTV-20, -21 and -23) to the region or distinct
(BTV-1, -2, -3, -4, -9 and16) fromtheir counterparts inother source-
sink episystems and belong to Eastern topotype. Apart from these,
serotypes of western origin are also found to be circulating (BTV-2,
-5, -7, -10, -12 and -24), and some (BTV-2 and -10) are indistin-
guishable from the live attenuated vaccines being used in Africa
(BTV-2) and USA (BTV-10). However, these two serotypes are not
reported outside India.
Conclusion: We could conclude that BTV-20, -21 and -23 are
unique to Australasian region and eastern topotype viruses of
serotypes BTV-1, -2, -3, -4, -9 and -16 have probably diverged from
theirwestern counterparts hundreds of years ago andevolved since
then. Among the serotypes of western origin, BTV-5, 7, -12 and -24
seem to have entered this area in the recent past and got estab-
lished in more than one country whereas vaccine strains of BTV-2
and -10 did not. Identiﬁcation of circulating serotypes of BTV in this
region is important for evaluating virus movement and for vaccine
design.
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Background: Indonesia reports the second highest dengue dis-
ease burden in the world. However these passive surveillance data
are recognized to be incomplete, to varywidelywithin the country,
and are likely signiﬁcant underestimates. Age stratiﬁed seropreva-
lence data are relatively unbiased indicators of past exposure and
allow understanding of transmission dynamics. These information
are valuable for public health planning, control and prevention
activities. A nationally representative population-based cross sec-
tional dengue seroprevalence study was conducted in 1 to 18 years
old urban Indonesian children.
Methods & Materials: Using a cluster design and a probability
proportional to size sampling, 3210 children from 1 to 18 years old
in 4 age groups (1 – 4; 5 – 9; 10 – 14 and 15 – 18 years old) were
enrolled, following household visits, from 30 clusters distributed
from west to east in urban areas of Indonesia. Serum samples were
tested for anti-dengue IgG antibodies by indirect ELISA. Using lin-
ear and catalytic models the median age of seroconversion and the
force of primary infection were estimated.
Results: Data from 3194 children (98.7%) were included in the
analysis. Overall, the adjusted national seroprevalence was 69.4%
[95%CI: 64.4-74.3] ranging from 33.8% [95%CI: 26.4-41.2] in the 1-4
year old, 65.4% [95%CI:69.1-71.7] in the 5-9 years old, 83.1% [95%CI:
77.1-89.0] in the 10-14 years old, and 89.0% [95%CI: 83.9-94.1] in
the 15-18 years old. Themedian age of seroconversionwas 4.8, and
considering a constant force of infectionwe estimated 137 primary
infections per 1000 children per year.
Conclusion: This is the ﬁrst nationally representative dengue
seroprevalence study conducted in Indonesia. Dengue seropreva-
lence is high in Indonesian children: over half of children have been
infected by the age of 5. This level of transmission intensity should
be associated with increased risk of secondary infection and thus
clinically and more severe disease. These data are an additional
indicator of national-level burden and will inform implementation
of preventive measures, including vaccination.
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